Enfermedad de Parkinson: fisiopatología y nuevos tratamientos
Ludwig Maximilian University of Munich
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (3)
2021
-
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Neurology, Vol. 97, Núm. 14, pp. E1367-E1381
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341
2013
-
Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis
PLoS ONE, Vol. 8, Núm. 11